<code id='B28417B730'></code><style id='B28417B730'></style>
    • <acronym id='B28417B730'></acronym>
      <center id='B28417B730'><center id='B28417B730'><tfoot id='B28417B730'></tfoot></center><abbr id='B28417B730'><dir id='B28417B730'><tfoot id='B28417B730'></tfoot><noframes id='B28417B730'>

    • <optgroup id='B28417B730'><strike id='B28417B730'><sup id='B28417B730'></sup></strike><code id='B28417B730'></code></optgroup>
        1. <b id='B28417B730'><label id='B28417B730'><select id='B28417B730'><dt id='B28417B730'><span id='B28417B730'></span></dt></select></label></b><u id='B28417B730'></u>
          <i id='B28417B730'><strike id='B28417B730'><tt id='B28417B730'><pre id='B28417B730'></pre></tt></strike></i>

          Home / fashion / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:73
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In